|
|
- かずただ みやくぼ
- 7 years ago
- Views:
Transcription
1 K O S A I P P P P P P P P P
2
3
4 2 F ICU 3 F
5 4 F 5 F RCU
6 CT
7
8
9
10
11 [C PAP] C-PAP C-PAP C-PAP C-PAP RFA PEIT IVH
12 TEL FAX
ACS34_07高柳.indd
1. ICU 2002 2005 2006 32 ICU 1) 2) 3) 3 2. 2.1. 123 8 (1716 1735) ICU 1736 2 1 3 4) ICU 5) 2.2. a 1923 110 30 6) 1924 15 16 7) 8) ICU 1 1935 9) 1930 1 120 10) 1936 11) 12) 124 b 1917 1927 1922 13) 14)
More information8 8 0
,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7
More information-1- -2- -3- -4- -5- -6- -7- -8- -9- -10- -11- -12- -13- -14- -15- -16- -17- 1. 2. 3. -18- -19- -20- : : : : -21- 3 # # # 25 17 51 13 41 12 25 3 10 23 10 5 30 66 15 8 5 3 88 144 284 67 50 37-22- -23- -24-
More informationDigital Photo Professional Ver1.6(Windows)
Windows CT1-5193-000 CANON INC. 2005 J 1 2 3 4 s s s 1 1 s s s s s 1 1 a s s 1 s s 1 2 s a 1 s a 2 3 1 1 s a a 2 a 3 a s s 1 a a s a s s 1 s s 1 2 3 s 1 1 a 2 a 1 a s 2 3 1 1 s a 2 1 3 1 s a 2
More information救急車同乗実習レポート 総括
14 9 1 9 10 10 19:00 23:00 52 1 6.5 40 CT X CT Ope 15 /min BP 100/70mmHg HR 96 /min O U m 60 25/min BP 140/80mmHg HR 55 O Spo 98 BP 172/68mmHg O 30 15 /min BP 100/60mmHg HR 80 /min BS O O CO 30 40 JCS
More information! ! ! a b SIMV 12/min 0 (cmh 2O) 500.0 P/F (cmh 20) 8 0 (cmh 20) 6 400.0 300.0 200.0 100.0 (cmh 2O) 200 180 160 140 120 100 80 60 40 20 0 PS in 2043 2257 2115 2723 3022 3400
More informationICU ( ) ICU ( ) ICU SpO 2 ICU ( ) -297 S.E DEX: N=30 DEX: N= 6 (J-DEX Placebo: N=30 Placebo: N= 3 65 DEX: N=16 DEX: N= 3 Placebo: N=
ICU ( ICU ( ICU SpO 2 ICU ( -297 S.E. -75-94 65 DEX: N=30 DEX: N= 6 ( Placebo: N=30 Placebo: N= 3 65 DEX: N=16 DEX: N= 3 Placebo: N=19 Placebo: N= 4 65 DEX: N=53 DEX: N=42 DEX: N=21 DEX: N=10 ( Placebo:
More information104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26
25 25 3 5 MMR 1 104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 2012 8 31 1,032,660 132 ( 0.013 ) 3 2010 6 11 3 11 15.4 1 1 ( ) 12 2 2 3 ER ) (
More information2
1 2 17 1884 2 131 1 1..He lived to serve 2 2 2 2 14,416 104,000 1 QOL Quality of Life 2 21 2013 25 21 3 4 5 QOL 6 QOL QOL 59 1 60 7 QOL QOL 8 2,774 2015 27 5 7 241 2015 27 5 8 12 2015 3 7 58 1,030 113
More information橡アロマセラピー症状別処方例.PDF
1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20
More information1 FEV1.0 FEV1.0 30 80% NIH FEV1.0 50 80% FEV1.0 50% FEV1.0 cyanosis PaO2 PaCO2 PaO2 PaCO2 40mmHg FEV1.0 25% 2 1 1 2
15 1 12 1 2 2 2 2.1.............................. 3 2.2........................... 3 2.3 β........................ 6 2.4............................ 7 3 8 3.1....................... 8 3.2....................
More information岐阜大学医学部・付属病院の現状と課題
1 21 2 100 6 16 35 5 5 MEDC 13 3 5 35 5 35 1 4 6 2 7 1 3 9 4 6 5 7 4 21 21 5 5 MEDC MEDC 13 2 12 5 17 1 1 96 16 7 62 5 3 8 8 10 21 50 3 1 ICU HCU CCU ICU 1 2 3 1 1 MINCUS 1 ICU 2 3 ICU HCU CCU 3 4 9 4
More information「東日本大震災に係る対応―保険診療・地域医療再生基金・災害復旧費補助金・医療法等について(第1報)」について
2012 3 28 2011 3 1 1 2012 3 2012 3 28 2012 3 28 2012 3 28 2012 3 28 1. 1 3 11 1 2 3 15 17 3 4 5 1 2012 3 28 5 10 6 3 18 7 5 8 3 23 9 2 2012 3 28 2011 3 23 23 10 3 2012 3 28 4 2012 3 28 5 2012 3 28 3 24
More informationICU/…A…WŁ¶32/10“‡Œö
V 1. 2002 1) 2) 12 2. 60 1941 12 1944 ICU B29 87 115 105 Z 54 1944 87 44 45 177 1945 4 21 22 8 3) 3. 1941 11 1 30 1944 2 1944 1 1941 8 4) 4. 5) 6) 5 1 50 7) 1944 4 1945 3 5 8) 4 3 160 1944 5 1945 3 3 3
More informationph
14 12 9 3 4 1 7 1.1..................... 7 1.2 ph............................ 9 1.2.1...... 9 1.2.2.... 12 4.4..... 55 1.2.3 14 4.4.1......... 56 1.2.4............. 19 2 21 2.1.......... 21 2.2......................
More informationSpO2 FIO2 Hypoxic Pulmonary Vasoconstriction HPV 30 FIO2 FIO2 PaCO mL/kg I/E CPAP P
11 a. 2012 1 15 26 http://www1.koalanet.ne.jp/anesth_memorandum/sub19.html SpO2 FIO2 Hypoxic Pulmonary Vasoconstriction HPV 30 FIO2 FIO2 PaCO2 20 30 8 10mL/kg I/E CPAP PEEP 27 b. CO2 ( ) SpO2 COPD PETCO2
More informationuntitled
........ ,..,..,..,,..,..,.. ,. , OECD ............ / :........................ :........ ... .. OECD OECD....... OECD Health Data ,, , :..... JR.... ,.. t-pa NICU ICU ICU.... NICU NICU NICU NICU.....
More informationuntitled
2009116 HP 4 50 50 1 2 20032 3 1001 5 255 AASM AASM AHI 4 PaCo2 PaCo2 PaCo2 PaCo2 PaCo2 PaCo2 PaCo2 COPD PaCo2 PaCo2 COPD (%) 100 80 60 40 20 0 () 100 75 1 50 25 45 65 0 25 50 75 () Fletcher, C. et al:bmj
More information‡æ‡©…l…b…gŒ{Ł¶58
12 10 21 12 13 13 14 1 1987.11 1982 1984 10 180 1989 No.11993 1982S57 1984S5910 1987S62 1987S6211 1989H 1990H 1991H 1991H 1992H 1993H No 1993H 10 1994H 1995 H 1996H 1997H24 1998H1023 1999H1122 2000H1227
More informationHR-ST700
HR-ST00 MULTI BRAND RCU 3 5 3 5 6 0 8 9 0/ OK/ LPT08-00B 0 50 5 59 6 38 3 8 5 6 3 33 3 8 9 50 5 5 53 5 55 56 58 59 6 63 6 38 0 3 5, 6 66 6 0 5 3 AC00V 5 6 3 5 6 8 9 0! @#$% ^ 38 3 3950 5 6 6 36 8 5 9
More informationS22 vol. 38 Suppl. 2013 38-3-2 38-3-3 38-3-4 38-3-5 JA 4 6 15 14:35 15:15 3 38-4-1 1 JA 38-4-2 10 38-4-3 38-4-4 5 5 6 15 15:20 16:10 3 38-5-1 1 38-5-2
vol. 38 Suppl. 2013 S21 1 6 15 11:25 12:15 4 38-1-1 38-1-2 US 38-1-3 1 38-1-4 38-1-5 2 6 15 13:40 14:30 3 38-2-1 1 38-2-2 38-2-3 CHI-Q 38-2-4 1 38-2-5 IgG4 3 6 15 13:40 14:30 4 38-3-1 S22 vol. 38 Suppl.
More information医療レーザー脱毛の威力と限界
.... mm. CT WH W H W H W H... kcalkcal. 1. cal kcal 1 6 2 3. 4. 5. 1 6 6. B6 B12 B. BMI BMI30 C. D. kg mm . CT WH W H W H W H... kcalkcal . 1. cal kcal 1 6 2 3. 4. 5. 1 6 6. B6 B12 B. BMI BMI30 C. D.
More informationHR-VT700
HR-VT00 MULTI BRAND RCU 3 5 3 5 6 0 8 9 0/ OK/ LPT09-00B 9 6 8 5 58 63 6 9 5 3 8 5 6 8 9 3 5 35 3 38 6 8 9, 50 5 5 53 5 55 56 5 58 59 60 6 63 66 68 5 8 9 80 8 83 3 AC00V 5 6 3 5 6 8 9 0! @#$% ^ 3 8 385
More information21 USDA 2006 USDA 06 0607
21 USDA 2006 USDA 06 0607 05 10 6,200 45 0631 202575 02 10 E-10 90 MTBE 90 MTBE 02MTBE 05 25MTBE 06 MTBE 06 25 01 05 201275 3.8 05 1,387 70 2104 0520.9 40 RFA 0610133 07 69 06 011,79005 4,060227 RFA2012
More information特許権侵害に対する損害賠償額の算定に関する裁判例の動向
[*361] 1998 1999 102 1 105 3 102 3 102 1 102 2 102 3 1. 2. 102 1 2.1 2.2 2.3 2.4 3. 102 2 3.1 3.2 4. 102 3 5. 1. 1) 102 1990 3 1 102 1 10 102 2 102 2 10 102 3 [*362] 2) 1998 1999 102 1 105 3 102 3 2 3)
More information2015 3 1.... 1 2.... 2 (1)... 2... 2... 3... 4 (2)... 5... 5... 6 (3)... 7 DPC... 7... 8 3.... 11 (1)... 11... 11... 12... 14 (2)... 15... 15... 16 (3)... 17... 17... 17 4.... 19 (1)... 19 (2) SWOT...
More information「学生とシニア」の対話実施報告書
in 2009.11.30 1. 2005 6 38 3 2 2. 3 3. 1 21 11 7 9301630 11 6 18302030 2 1 1 3 4 (90 )(50 )(75 ) 4. 5.(70 ) 6. 5 2 G1 (CO2 ) G2 () G3 () G4 (-) G5 () 5 2 10 1 CO2 Q&A 1 7. 3 2 3 9%, 62%, 27%, 2% 71% 23%,
More information評価結果報告書の概要版(平成20年度)
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76
More information() CT X X Ver.5 64 ( 3.0 % / 24,, 25 H23 1 Dr 24 24 2 1 25 RI RI ICU 24 25 B 4500 13000 AHA-PALS 5 PALS 24 25 24 25 24 ICU 24 25 24 1 VA VA 25 25 VA HD VA 20 150 () () 25 2 24 25 24 24 414 102 25
More information肝臓病教室201207v2配布用.pptx
24 7 28 5 C C C C 11 1 vs 2 vs 1 0 1 600-1000mg 3-5/ 24,48 2448 12 1 1500-2250mg 6-9/ () 1 600-1000mg 3-5/ 0 24 88.1% 0 20 40 60 80 100 C ALT, GPT 30 34.4% ALT, GPT 0 20 40 60 80 100 2 , 2 3 1 1-100% 0
More informationStage 28 4 28 7 !! 15 EMB POMRProblem Oriented Medical Record SOAPSubjectiveObjectiveAssessmentPlan 1 2 ID 3 ID SOAP 4 5 6 ~ ~~~~~~~~~~~~~ Stage Stage 2 1. X CT 2. 1 30 60 3. 5. 4
More information本文01id5.indd
1 TFT 9F 906 907 907 1 TFT 9F 906 90 1 P1-01 P1-02 1 1 1 2 1 1 2 P1-03 P1-04 P1-05 4 P1-06 P1-07 P1-08 1 1 1 2 1 2 P1-09 VCM TDM VCM 1 2 2 2 3 3 4 5 1 2 3 4 5 2 P2-01 P2-02 P2-03 83 1 TFT 9F 906 907 906
More information1 5 6 2 3 7 8 4 5 9 10 6 7 11 12 8 1 2 3 4 5 6 7 1989 25.0% 19901999 6 2000 15.0% 9 13 1 2 3 4 5 50 2 5180 45.0% 81 35.0%, 5.0% + +, 5.0% +, 1, 5 +, 3 14 10 0% 20% 40% 60% 80% 100% n=20 3 5 2 n=20 55.0%
More informationuntitled
7 ( ). 1. 2. 3. 4. 5. 6. . 1. (C.difficile associated disease CDAD) 1) CDAD 60 72 2 CDAD Toxin CDAD 2) (1) C.difficile C.difficile (2) C.difficile (toxin A toxin B) toxin A toxin B (A+B+) toxin A toxin
More information04_ポスター.indb
般ポスター基礎超音波計測一般 一般ポスター基礎 6 月 8 日 ( 金 ):00 - :0 ポスター会場 ( 神戸ポートピアホテル B F 座長 : 9- 基 P-00 S790 9- 基 P-00 S790 9- 基 P-00 S79 Jing ZHU, 9- 基 P-00 S79 9- 基 P-005 S79 9- 基 P-006 CT S79 Wenjing WU 9- 基 P-007 HIFU
More informationJPN-1
EF70-200mm f/2.8l IS II USM JPN JPN-1 a JPN-2 JPN-3 1. JPN-4 2. 3. JPN-5 4. JPN-6 5. JPN-7 6. JPN-8 7. JPN-9 JPN-10 8. 9. JPN-11 10. JPN-12 11. 12. 13. JPN-13 14. JPN-14 JPN-15 canon.jp/ef 050-555-90001
More informationMP-E 65mm f/2.8 1-5× 使用説明書
MACRO PHOTO LENS MP-E 65mm f/2.8 1-5 JPN JPN-1 a JPN-2 JPN-3 1. 2. JPN-4 JPN-5 JPN-6 3. JPN-7 JPN-8 4. JPN-9 5. JPN-10 6. 7. JPN-11 8. JPN-12 canon.jp/ef 050-555-90001 JPN-13 CT1-7525-010 CANON INC. 2002
More information32 TEL: 0959-52-3000 FAX: 0959-52-4467 Email: nkh@orange.ocn.ne.jp URL: http://www.kamigoto-hospital.jp/ 1 73 MRI IT IVR PTCA 74 MC CT) NECMega-Ork 75 Web HTLV-IATL 2 ICU Holter MD-C T MRIX DSAFCR 3 4
More information2007 116 20 1 19 2 6 2 19 2 2007 4 2
http://www.shijuku.net 2007 116 20 1 19 2 6 2 19 2 2007 4 2 1/14 New Years Party 2007 In NEW YEAR PARTY 330 Wii 4 Wii ii 1/14 NEW YEAR PARTY 11 277-0852 1-6-5 04-7141-5101 04-7141-5106 www.sougakusya.com
More information: : BSC - - :
2013 : : BSC - - : - - 58 30 9 70 3 3 1 Association of genetic variants of the α kinase1 gene with myocardial infarction in community dwelling individuals Abstract. ALPK1 ALPK1
More information21 8 20 70 1 1 2 1 1 20 12 22 16201835 2 21 1 21 15001910 3 21 2 23 15001750 4 21 3 23 15002030 5 21 4 27 15102010 6 21 6 15 15002110 7 21 7 27 15001910 2 3 3 21 3 21 4 2 4 1 2 1 2 312 4 3 1 2 3 4 2
More informationACSS21_06梅津.indd
70 60 ICU ICU ICU ICU ICU 14 14 1970 25 ICU ICU 55 ICU ICU 2014 140 ICU 1952 8 7 23 5 1 7 5 10 22 Tokyo Anglo-Japanese Seminary The Methodist Mission Seminary ICU 56 6,000 ICU ICU ICU ICU Academy, College,
More information平成15年度先進的情報技術活用モデルシステムの開発
2 3 IT SI (1) (2) (3) (4) 24 (1)(4) 61 FM CATV IT 500 320 8,000 16 12 4 1 5 CT NTT ADSL ()( MIL )(DICOM ) () MIL (Web) / Web 2 6 (Web)CT 3 7 ( ) 24 4 8 DICOM CT () 9 5 CMC() () () ()NTT-ME 10 ( ) () CT
More informationuntitled
11 10 267 6 129 48.3 6 63 2 1 2JIS ME JIS T 1005JIS 1994 1 11 A 10 1999 5 3 13 ME 4 2 11 B B 1999 4 10 267 6 B 7 9 6 10 12 3 11 Excel MODE Excel STANDARDIZE STANDARDIZE(X,)X AVERAGE STDEVP Excel VAR 0.5
More informationカラーイメージランナー iRC5870/C5870N カタログ
LIPS LX LIPS LX PostScript3 LIPS LX LIPS V LIPS V PS Apple Talk PAP TCPIP SMB LPR IPP Port9100 PRODUCT OUTLINE PRODUCT OUTLINE Dummy ENGINE IMAGE CONTROL IMAGE CONTROL PAPER HANDLING PAPER HANDLING ENVIRONMENT
More informationA 01 2 015 10 11 12 G 011 2 0111 67
66 A 01 2 015 10 11 12 G 011 2 0111 67 0119 0112 0113 68 0130 0128 0114 0113 0115 0116 0119 69 0111 0128 012 2 0121 1102 0122 0123 0124 70 0125 0126 0126 0111 0127 71 0128 0129 0230 013 0130 0130 011 012
More information10 35 10 1 1 5 1 2 3 2 1 34 37.000 28,000 75 203 208 655 7,000 8,000 655 7 70 7 10 1 1,700 5,500 2 7 2 3 9 34 3 4,100 9 1,800 1 1 34 5,800 4,200 470 280 3400 32 1 5 97.8 7 3 34 65 1 40 70 1 2 9 3 3 1 6
More informationNIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml
NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008
More information- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - 20log10 150 = 44 20log10 150 = 44-7 - - 8 - - 9 - - 10 - L ks X n + X 2 2 ) ( 1) ( 1 = X X n S n n n X L k k n X n X S n L n k - 11 - - 12 - - 13 - - 14 - - 15 - - 16
More informationPSCHG000.PS
FA X SA RS W H O DM AT ACLS TR BCG BCG GDP GDP JO A JC O A ATL W H O GNP OB g ICLS IC L S AED IC L S AED AED Dr. a ODA b c d d d d ddic d c VT VT VT VT VT VT VT VT VT VT VT VT c
More information面付 北斗No16本文
1619310 27202724 920-0293 1-1 TEL076286-2211 FAX076286-8214 25 80 30 17 9 10 10 1 10 1 1015 1022 1023 1026 1029 1029 1030 11 2 11 9 1113 1115 1119 1120 1121 1126 1127 1127 1130 1210 1226 20 342 302 33
More informationuntitled
1 ( ) ( ) QMS-H ( ) ( ) 27 ( ) ( ) GK SHIAN CREATIVE PARTNERS 28 2 ( ) () NTT ( ) () ( ) 29 3 () 15-1 A 1) 1) 1) 1) 1) 2) 3) 4) 1) 2) 3) 4) 15-2 15-3 1) 2) 3) 4) 1) 2) 3) 4) 15-4 ( ) 16-1 16-2 1) 2) 1)
More informationuntitled
59 2014 712 59 2014 712 59 171 3F 2F 1F B2F B3F B2F 900 1 2 3 900930 900 1630 30940 1000 1100 9401140 9401050 1 D11 D17 10501200 3 9 D31 D37 9401050 2 10501200 D21 D27 4 D41 D47 1200 1300 12101310 1 12101310
More informationがん診療におけるFDG FDG-PET/CTの役割
PET/CT PET/CT MRI PET PET/CT Kurashiki Central Hospital FDG-PET CT PET/CT (stage1) FDG-PET (stage1) PET/CT FDG-PET PET/CT (stage4) FDG-PET (stage4) PET/CT FDG-PET PET/CT PET/CT
More informationprogram.pdf
- - FAX E-mailjsnr-office@umin.ac.jp http://jsnr.umin.jp/ Cheryle Tatano Beck Vol. No. ,,, PC Vol. No. USBCD-ROM PC PCOS Windows XPPowerPointMS MSMSP PC Vol. No. , Vol. No. Vol. No. 会場までの交通機関 日本看護研究学会雑誌
More information平成18年度厚生労働科学研究費補助金
19 3 19 3 目次 1 要旨 1 2 本文 第 Ⅰ 部 在宅医療計画の主旨 Ⅰ-1 在宅医療とは 3 Ⅰ-2 在宅医療計画の背景 : 国民のニーズと医療提供実態のミスマッチ 3 Ⅰ-3 医療計画における在宅医療の位置づけ 12 Ⅰ-4 在宅医療機関及び各連携機関とは 14 Ⅰ-5 在宅医療計画の展開 32 Ⅰ-6 医療費適正化計画 介護保険計画との整合性について 34 第 Ⅱ 部 利用者の視点に立った在宅医療計画の概要
More informationCT_08-01.ai
2009-12 CT55DD 80,000 CTF55B 8,000 CTF55D 3,200 41m 2 BIO HEPA ECO 5 21 20m 2 1210 4.3 1,542 http://www.kuusei.jp/ https://ssl.mhiair.co.jp/app/ contact/?form_number=3 https://ssl.mhiair.co.jp/shop/
More informationuntitled
1 ... 3... 3... 3... 4...13...16...18...20...22 2 PTPE 3 PTPE CT Grade 2 A PTPE PTPE 4 A S 3 3 B H3,P1,N1,M1, LM0, R23 15 20gS, ptype 3, 60 x 50mm, pt4b/siurinary bladder, int, INF, ly2, v1, ppm070mm,
More information原発緊急講演
2011 3 11 2 46 9.0 2011 2 22 11,000 1995 1 17 7.3 350 1923 9 1 45 tsunami 1 6 1 3 4 6 1 3 1,3 2 1 Bq 1 PBq 1000 85 10.7 22PBq 90 28.8 190PBq 95 64 5900PBq 106 372 700PBq 131 8 3100PBq 133 5.24 6300PBq
More information第1回日本産婦人科
e e TEL045-231-0960 TEL03-3433-1111 3360 4 2 1 1024768 OS RGB -15pins Dsub-15pins PowerPoint PC WindowsXPMicrosoft PowerPoint2002 Microsoft Power Point ( PC ) Windows USB CD-R PC 30 PC PC 36
More information... 3 CT
CT915 ... 3 CT915... 4... 5... 6... 7... 11... 14... 16... 18... 19... 22... 24... 25... 26... 28... 29... 30... 31 2 3 CT915 120 120 1 1 31 31 4 CT915 s t CR2032 5 1. 2. 5 3. 6 CR2032 CR2032 1. / 1 2.
More information数学演習:微分方程式
( ) 1 / 21 1 2 3 4 ( ) 2 / 21 x(t)? ẋ + 5x = 0 ( ) 3 / 21 x(t)? ẋ + 5x = 0 x(t) = t 2? ẋ = 2t, ẋ + 5x = 2t + 5t 2 0 ( ) 3 / 21 x(t)? ẋ + 5x = 0 x(t) = t 2? ẋ = 2t, ẋ + 5x = 2t + 5t 2 0 x(t) = sin 5t? ẋ
More information連携だより34号_201504_034
新センター長挨拶 連携センターからのお知らせ なかつ地域医療連携勉強会 なかつ病院市民講座 部門紹介 入院支援室 診療体制のお知らせ / 新任 退職ドクター紹介 第 34 登録医募集 / 受付時間のご案内 号 2015 年 4 月 CLOSE UP! 診療科 老年内科 社会福祉法人 恩賜 財団 済生会 大阪府済生会中津病院 地域医療連携センター 2015 1 1 11 2 24 12 2 FAX CCU
More information1
1 6 7 8 9 10 11 12 13 14 15 21:00 22:00 23:00 24:00 18:00 19:00 20:00 16 1 3 ). ). ). 6 ). ). 9 10 12 ). ). 15 ). ). ). 20 ). ). ). 26 2 ). 2 39 3 ). 1. 2. 3. 4. 4 5. 6. ). 5 ). ( ) ( TWITraining
More informationuntitled
1 N=14,685 2 3 4 5 6 CT 7 8 9 10 11 540 3female athlete triad) growth spurt,growth rush Cm/ 15 10 5 7 10 15 12 13 Oslo Sports Trauma Center 1992 Bahr,R.Br.J.SportsMed. 2005 ACL ACL ACL ACL a: b: 5 14 15
More information" " 8 4 5 psyche 8 10 10 12,000 10 24 1 10 7 1 4 1
(This is NOT the actual test.) No.000001 0. ICU 1. 2. 42 (1-42) 3. 90 90 4. 5. 6. 7. 8. 88 Edited by www.bucho-net.com " " 8 4 5 psyche 8 10 10 12,000 10 24 1 10 7 1 4 1 Edited by www.bucho-net.com 1 2
More information< F2D C8E8691E63395AA8DFB2E6A7464>
1990 CPUE ABC 2-1)ABClimit= 1 Ct 1 =0.6 Cave 1.00 0.8 ABCtarget=ABClimit 0.8 Ct 3 Cave2008 2010 2011 2013ABC ABClimit 170 0.6Cave3-yr1.00 ABCtarget 140 0.80.6Cave3-yr1.00 Cave20082010ABC10 2010 263 2011
More informationM.D.I VDT 29. (1)
5. 5. 5.1 (1 (2 (3 (4 3040 5.2 32 1 1 43 2 44 3 45 13 14 1) 4 45 2 5 46 6 47 7 66 2 8 26 2 1 32 2) 1 2 53 3 39 4 40 5 56 6 29 7 38 8 22 9 22 3 48 2 29 5. 17 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14.
More informationPSCHG000.PS
Interventionalbronchology FA X W G CTM RIAiautopsy im aging Ai Ai P Huganir CT CT RSH HV % % IC U c c c c cc cc cc cc cc c c c c c c c c c c c c c c c c c c c c Hib b Hib H ib H ib PD A IC PD A f
More informationYouth for 3.11 2011
Youth for 3.11 2011 Youth for 3.11 Youth for 3.11 2011 Youth for 3.11 Vision Mission : 1Youth for 3.11 2Youth for 3.11 3Youth for 3.11 Youth for 3.11 Youth for 3.11 Youth for 3.11 Youth for 3.11 Youth
More informationThe Lancet NPPV July18, 2009 Non-invasive ventilation in acute respiratory failure ( Review)The Lancet, vol. 374, July 18, 2009 H22.9 The Lancet 2009
The Lancet NPPV July18, 2009 Non-invasive ventilation in acute respiratory failure ( Review)The Lancet, vol. 374, July 18, 2009 H22.9 The Lancet 2009 7 18 NPPV NIV: non-invasive ventilation review NPPV(Non-invasive
More informationPAP PAP05A1 PAP05A1-F PAP10A1 PAP10A1-F PAP20A PAP20A-F AIR WATER PAP05A1 PAP05A1-F PAP10A1 PAP10A1-F PAP20A PAP20A-F PAP10A1 15
PAP PAP05A1 PAP05A1-F PAP10A1 PAP10A1-F PAP20A PAP20A-F PAP05A1 PAP05A1-F PAP10A1 PAP10A1-F PAP20A PAP20A-F PAP10A1 15 PRECISION PROCESSOR PAPSERIES PAP PAP05A1-W PAP05A1-FW PAP10A1-W PAP10A1-FW PAP20B1-W
More information表紙/オレンジDIC164 背4.5mm
An overview of regular dialysis treatment in Japan as of Dec. 31, 2004 Japanese Society for Dialysis Therapy An overview of regular dialysis treatment in Japan as of Dec. 31, 2004 Japanese Society for
More information2
1 2 3 1) 2) 3) 2 3 1 2 3 4 5 6 7 8 9 10 11 4 12 13 14 15 X 16 X 17 X CT 18 MRI 19 20 4 A. ENG T&T B. ABLB SISI ABR ASSRMLRSRL 5 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 6 1 2 3 4 7 1 POS( Problem
More information10K1A NASA () SPACE ATLAS Freedom H2A NASA 1
10O1A 10 10 1 10K1A NASA () SPACE ATLAS 40 1957 1969 10 1986 1990 Freedom 20 000 H2A NASA 1 10K1A 100 10 21 40 1996 ( 200 () 2 10S1A 10 8 57 250 1 10S1A 20 200mmm 2 10S1B 18 18 1 10S1B 40 10 20 2 10S1C
More informationE-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1-
E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1- LD LD LD -2- MBD Minimal Brain Dysfunction Syndrome -3- Minimal Brain Dysfunction Syndrome : --- WISC-WPPSIK-ABC --- CTMRIEEG --- 40 60-4- -5- MBD MBD MBD MBD
More information山田H17秋セメ.PDF
1 21 2 1 IT 1 2 1 IT IT 2 1980 24 24 3 2005 10 5 4060 309 53 91 87 75 NHK 2 2005 10 10 2004 4 12,007 49,337 6,000 * * * * 500 5 2004 6 12,457 11,636 18.8 15.1 2000 50 9 7 1 100 50 8 3 6 9 1 2 48 2 24.5
More informationTrv1_.xtv
第 0 回 PBF 選手権日本代表選抜試合ウィメン予選 ession 1 01 年 11 月 1 日 ( 土 ) 1 Board (1) - -W Contract L - -W IMP H D H C 0 Board () - -W Contract L - -W IMP H -1 D 0 H -1 D 0 Board () - -W Contract L - -W IMP T -1 D 0 D
More information< A815B B83578D E9197BF5F906697C38B40945C F92F18B9F91CC90A72E786C73>
がんに対する診療機能 各領域の専門医に加え 認定看護師 専門 認定薬剤師等とともにチーム医療を展開しており 標準的かつ良質 適切な医療の提供に努め 又 他の医療機関との連携を推進しております. 肺がん 当該疾患の診療を担当している 医師数 当該疾患を専門としてい 腫瘍内科 4 4 2 腫瘍外科 ( 外科 ) 5 4 3 腫瘍放射線科 実績実績実績 開胸 治療の実施 (: 実施可 / : 実施不可 )
More informationS E N S O R S September 2016 CCT CCT CCT CCT CCT CCT261631
S E N S O R S September 2016 CCT CCT406393 CCT354571 CCT323047 CCT272440 CCT261631 (2/13) ( ) ( ) ( ) AV (3/13) RoHS CCT RoHS HEMS BEMS FEMS CEMS CCT 406393-600 - 36-00 40 600 600A 36 36mm 63 W 300 300A
More information20●12頁●6-14▲放射線科▲.ppt
No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%
More informationニュースレタ-8号最終
QOL IVPCA IVPCAPCA DPC IVPCA PCA IVPCA http://shirobon.net/26/ika_2_11 2018 19 2016 100 2016 40 40 50 60 2014 4 2014 4 6 8 2014 7 2014 2014 7 18 JR a. b. c. 20 100 6 100010 ICU 3 6 C'est la vie hemoglobin
More information(核)41-1(05)報告33-46
33 Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 28th Survey in 2002) 6 * Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope
More information天草郡市医師会第139回(臨時)代議員会
A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (
More information116_0431_0443.doc
1 0Recognized E 60389 Certified LR 20812 PA PAPAFPAL CONNECTOR 2 PAPAPAFPAL CONNECTOR PAPAPAFPAL CONNECTOR 3 1 2 PAPAPAFPAL CONNECTOR 1 2 4 5 PAPA CONNECTOR SPHD-001T-P0.5 SPHD-002T-P0.5 PAP-02V-S PAP-03V-S
More information116_0431_0443.doc1
1 0Recognized E 60389 Certified LR 20812 PA PAPAFPAL CONNECTOR 2 PAPAPAFPAL CONNECTOR PAPAPAFPAL CONNECTOR 1 2 3 PAPAPAFPAL CONNECTOR 1 2 1 2 4 5 PAPA CONNECTOR SPHD-001T-P0.5 SPHD-002T-P0.5 PAP-02V-S
More informationTitle 大動脈解離の高速らせんCT : 腹部大動脈分枝についての検討 Author(s) 早野, 千恵 Journal 東京女子医科大学雑誌, 63(11):1399-1406, 1993 URL http://hdl.handle.net/10470/8839 Twinkle:Tokyo Women's Medical University - http://ir.twmu.ac.jp/dspace/
More information156 51 1 2015 2 3 6 1 1) 2) 3) 1) 1) 1) 1) 1) 2) 3) 3) 3 1 4 6 2 3 4 Rocky Mountain Soap Rocky Mountain Soap RMS Canmore Banff Pure hand-made 100 toxi
51 1 2015 2 pp. 155-173 155 25 QOL 26 10 18 1993 2000 23 25 3 IT 10 2 end of life living will living will living will 1 NICU QOL NICU QOL 3 6 kg NICU 42 2 kg 2007 NICU 2 NICU/ GCU 25 4 26 3 3 A 156 51
More informationEOS DIGITAL ソフトウェアガイド
EOS DIGITAL EOS Viewer Utility EOS Capture PhotoStitch Windows Macintosh EOS-1D Mark II EOS-1Ds EOS-1D J s Windows Macintosh Windows Windows Macintosh Windows w 1 2 3 4 5 6 7 1 W 1 1 2 3 4 1 2 a 3
More information